![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Stip Emmanuel Moteshafi Hoda
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.12, 2012-12, pp. : 1183-1184
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 1, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Safety, Vol. 28, Iss. 8, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Robert Ravasio on behalf of the authors
Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Touw Daniël J. Westerman Elsbeth M. Sprij Arwen J.
Clinical Pharmacokinetics, Vol. 48, Iss. 5, 2009-05 ,pp. :